On the recordDecember 11, 2019
Madam Chair, I yield myself the balance of my time. Addressing the rising cost of prescription drugs is a complicated issue, as Mr. Brady has noted, and it needs a thoughtful approach. H.R. 3 is a critical step toward a long-term, sustainable solution. A lot of hard work went into crafting this measure and, indeed, bringing it to the floor. And there are a number of staff to thank. From the Legislative Counsel's Office: Jessica Shapiro, Karl Hagnauer, Lisa Castillo, Adam Schilt, Fiona Heckscher, James Grossman, and Henry Christup. From CBO: Tom Bradley--who, I might add, is retiring after long and distinguished service, and we thank him for that--Paul Masi, Rebecca Yip, Lara Robillard, Chad Chirico, Alice Burns, Stuart Hammond, Lori Housman, Jennifer Gray, and Leo Lex. From the Joint Committee on Taxation: Tom Barthold, Vivek Chandrasekhar, Shelley Leonard, Chia Chang, Lin Xu, and James Elwell. From CMS: Manda Newlin, Maia Larsson, Ira Burney, Lisa Yen, Jen Druckman, Stacy Harms, Leigh Feldman, and Jenny Keroack. And, of course, as always, I want to thank the staff of the Ways and Means Committee, who, as usual, have worked tirelessly and effectively on this legislation. The legislation before this House today is in no small part because of their expertise and their commitment to improving the healthcare for all members of the American family. I thank Amy Hall, Sarah Levin, Melanie Egorin, Rachel Dolin, Orriel Richardson, Neil Patil, and Morna Miller.…





